SCHEMBL7777655

SCHEMBL7777655

CC=Cn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(C)cc2)c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.46
CA9 Q16790 13/20 0.44
CA12 O43570 12/20 0.44
CA2 P00918 9/20 0.42
CA1 P00915 7/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
CA3 P07451 2/20 0.40
CA6 P23280 2/20 0.40
CA5A P35218 2/20 0.40
CA7 P43166 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
PTGS1 P23219 4/20 0.39
PTGES O14684 1/20 0.39
HDAC3 O15379 1/20 0.39
PDPK1 O15530 1/20 0.39
PDE5A O76074 1/20 0.39
ABCB11 O95342 1/20 0.39
MT-CO2 P00403 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777305 0.90 PTGS2 (0.47) PTGS2CA9CA12CA2CA1
SCHEMBL7777300 0.90 PTGS2 (0.48) PTGS2PTGS1CYP2C9
SCHEMBL7780023 0.85 CA9 (0.45) PTGS2CA9CA12CA2CA1
SCHEMBL8627619 0.83 F10 (0.37) PTGS2CA9CA12CA2ENPP3
SCHEMBL7773227 0.81 PTGS2 (0.49) PTGS2CDK2PTGS1ABCB11
SCHEMBL7779590 0.80 KMT2A (0.47) PTGS2CA9CA12CA2CA1
SCHEMBL7773256 0.80 PTGS2 (0.54) PTGS2CA9CA12CA2CA1
SCHEMBL7780664 0.80 PTGS2 (0.43) PTGS2PTGS1
SCHEMBL7779817 0.80 CA9 (0.48) PTGS2CA9CA12CA2CA1
SCHEMBL7777559 0.80 PTGS2 (0.48) PTGS2CA9CA12CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed